Page 70 - Orphan News Today

Press ReleaseNicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell DiseaseMarch 2nd, 2022 - release at 7:30 am CET Sophia

ENGLEWOOD, CO / ACCESSWIRE / March 2, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the European

It would be hard enough for a child to pick up and leave their country with their family, but imagine fleeing without your parents. It's the reality for the children under the watch of a Williamsburg nonprofit, whose mission is to get children out of dangerous situations safely.

STOCKHOLM, Feb. 25, 2022 /PRNewswire/ -- Sobi today announces that the Center for Drug Evaluation (CDE) has recommended approval of Gamifant to the National Medical Products Administration of

On Monday February 14, 2022 the German Federal Court of Justice decided on PEC's challenge of the award in the dispute between AOP Orphan Pharmaceuticals GmbH and PharmaEssentia Corporation. The decision

STOCKHOLM, Feb. 10, 2022 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announces its results for the fourth quarter and full year of 2021. Link to report below. Investors

GREENSBURG — Decatur County residents Dyar and Sheryl Soendlin are hoping to adopt a little boy from the Ukraine.

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic

Lately, I see “the unhoused” in the place and stead of “the homeless”. I know that meaning contracts and expands with usage, but sentences don’t usually come equipped with expansion

Pre-clinical studies demonstrated beneficial effects of SEFA-6179 in preventing the development of parenteral nutrition-induced cholestasis and liver injury associated with intestinal failure associated